EVIDENCE

Standing Committee
on

INDUSTRY

Chairman: David Walker, Lib.

Meeting No. 57

Wednesday, March 19, 1997

ORDER OF THE DAY:

Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)

WITNESSES:

Association of Canadian Medical Colleges:

Arnie Aberman, Member, Council of Deans.

Association of Deans of Pharmacy of Canada:

Robert Goyer, Dean, «Faculté de pharmacie, Université de Montréal».

Clinical Trials Atlantic Corporation:

Peter Thompson, Chief Executive Officer.

Coalition for Biomedical and Health Research:

Michel Bergeron, Doctor, Member of the Board and President, Canadian Society for Clinical Investigation, and Chair, Department of Microbiology, Laval University;

Barry McLennan, Doctor, Chair, Assistant Dean, Research, College of Medicine,University of Saskatchewan.

Department of Physiology:

Mark Bisby, Professor, Head, Queen's University.

«Université de Montréal»:

Suzanne Bisaillon, Professor, Faculté de pharmacie, lawyer;

René Simard, Rector.

University of British Columbia:

Bernard H. Bressler, Vice-President, Research.

Click here to view Committee Evidence

;